Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008) |
---|
09/21/1999 | US5955610 Antiviral compounds |
09/21/1999 | US5955600 Method for the synthesis of nucleotide or oligonucleotide phosphoramidites |
09/21/1999 | US5955599 Condensing in presence of 1h-tetrazole, a methoxy-3'-o (phosphoramidite) 5'-o-(4,4'-dimethoxytriphenyl) methyl nucleoside with another nucleoside; removing protective group without demethylating linkages |
09/21/1999 | US5955591 Phosphotriester oligonucleotides, amidites and method of preparation |
09/21/1999 | US5955589 Gapped 2' modified oligonucleotides |
09/21/1999 | US5955447 Administering as anticoagulant; treating cardiovascular disorders |
09/21/1999 | US5955446 Viricides for herpes infections |
09/21/1999 | US5955285 Method of identifying individuals at risk of suffering from cerebral amyloidosis |
09/17/1999 | CA2266089A1 Methods for producing nucleoside derivatives and intermediates therefor |
09/16/1999 | WO1999045935A1 Novel nucleoside analogs and uses in treating disease |
09/16/1999 | WO1999024452A3 Pyrimidine derivatives for labeled binding partners |
09/16/1999 | WO1998041531A3 Solvent for biopolymer synthesis, solvent microdroplets and methods of use |
09/16/1999 | CA2322494A1 Novel nucleoside analogs and uses in treating disease |
09/15/1999 | EP0942000A2 2'Modified oligonucleotides |
09/15/1999 | EP0941370A2 Stabilized aqueous nucleoside triphosphate solution |
09/15/1999 | EP0941314A1 Target nucleic acid sequence amplification method |
09/15/1999 | EP0941099A1 Method of treating bronchitis with uridine triphosphates and related compounds |
09/15/1999 | CN1228785A Synthetic polysaccharides, preparation method therefor and pharmaceutical compositions containing same |
09/15/1999 | CN1228770A Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties |
09/15/1999 | CN1228704A Cytotoxic amino sugar and related sugar derivatives of indolopyrrolocarbazoles |
09/14/1999 | US5952500 Nucleoside derivatives |
09/14/1999 | US5952499 Therapeutic compound-fatty acid conjugates |
09/14/1999 | US5952478 Nucleotides and analogs in which both the 3' oxy linkage and the 5' oxy linkage are replaced by carbon linkages; for antisense agents; viricides against influenza, herpes and human immune deficiency virus; anticarcinogenic agents |
09/14/1999 | US5952312 NADH and NADPH therapeutic agents for nasal, sublingual, rectal and dermal administration |
09/14/1999 | CA2170869C Amine-derivatized nucleosides and oligonucleosides |
09/14/1999 | CA2130664C Antiparasitic agents |
09/14/1999 | CA2118491C Avermectin difluoro derivatives |
09/13/1999 | CA2232074A1 Granulatimide compounds as g2 checkpoint inhibitors |
09/10/1999 | WO1999045016A2 Novel prodrugs for phosphorus-containing compounds |
09/10/1999 | WO1999044646A1 Novel imaging agents and methods for the preparation and use thereof |
09/10/1999 | WO1999029710A3 Purification method for producing fludarabin phosphate |
09/08/1999 | EP0939637A1 Method of treating sinusitis with uridine triphosphates and related compounds |
09/08/1999 | EP0510085B1 Dna-dependent rna polymerase transcripts as reporter molecules for signal amplification in nucleic acid hybridization assays |
09/07/1999 | US5948903 Nucleosides incorporated into oligonucleotides for antisense agents; compounds have unique steric properties, have better cellular transport properties and are adapted for placement into the minor groove of hybrid structure |
09/07/1999 | US5948648 Base portion, rigid linker, spacer, and linkage pair or label; for use as chain extenders or chain terminators in sanger sequencing reactions or polymerase chain reactions |
09/07/1999 | US5948624 Methods for the detection and isolation of biomolecules |
09/07/1999 | CA2028416C Anhydrous crystal of 4-carbamoyl-1-.beta.-d-ribofuranosyl imidazolium-5-oleate |
09/02/1999 | WO1999043691A1 2'-fluoronucleosides |
09/02/1999 | WO1999043690A1 L-4'-arabinofuranonucleoside compound and medicine composition comprising the same |
09/02/1999 | WO1999043313A1 Compounds and methods for use in treating neoplasia, cancer, hyperproliferative cell growth and chronic inflammatory diseases |
09/02/1999 | WO1999029702A3 METHOD FOR SYNTHESIZING 9-(2,3-DIDEOXY-2-FLUORO-β-D-THREO-PENTOFURANOSYL)ADENINE (β-FddA) |
09/02/1999 | CA2321715A1 Compounds and methods for use in treating neoplasia, cancer, hyperproliferative cell growth and chronic inflammatory diseases |
09/01/1999 | EP0938322A2 Use of uridine triphosphates and related compounds for the prevention and treatment of pneumonia in immobilized patients |
09/01/1999 | CN1227491A Method for treating sinusitis with uridine triphosphates and related compounds |
09/01/1999 | CN1044911C Method for preparing prodrug |
08/31/1999 | US5945547 Imtermediate in process to make 2', 2'-difluoronucleosides |
08/31/1999 | US5945527 Reacting cytosine containing a leaving group attached to 5- or 6-postion of molecule, isolating modified nucleoside; for novel fungicides, viricides, bactericides, antitumor agents |
08/31/1999 | US5945524 Nucleoside with dansylethoxycarbonyl group as base-labile 5'-hydroxyl protective group; for efficient synthesis |
08/31/1999 | US5945521 Preparation of phosphorothioate oligomers |
08/31/1999 | US5945406 Anticancer agents; treatment for metastatic liver cancer, fungal infections, psoriasis; used in manufacture of drugsto prevent cell division |
08/26/1999 | WO1999042617A1 Levo-monosaccharide in a nucleoside analog for use as an antiretroviral agent |
08/26/1999 | CA2320743A1 Levo-monosaccharide in a nucleoside analog for use as an antiretroviral agent |
08/24/1999 | US5942497 Purine compound and catecholamine compound containing compositions and methods for administration |
08/19/1999 | WO1999041275A1 Prodrugs |
08/19/1999 | WO1999041268A1 Nucleosides |
08/19/1999 | WO1999041267A1 2-(purin-9-yl) -tetrahydrofuran-3, 4-diol derivatives |
08/19/1999 | WO1999040916A1 Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds for treating hepatitis virus infections |
08/19/1999 | WO1999024451A3 Adenosine a1 receptor agonists |
08/19/1999 | WO1999024450A3 Adensine a1 receptor agonists |
08/19/1999 | WO1999024449A3 Adenosine a1 receptor agonists |
08/19/1999 | CA2319009A1 2-(purin-9-yl) -tetrahydrofuran-3, 4-diol derivatives |
08/19/1999 | CA2318978A1 Prodrugs |
08/19/1999 | CA2318975A1 Prodrugs of 2'3'-dideoxy-3'-fluoro guanosine |
08/18/1999 | EP0935466A1 Method and composition for inhibiting cellular irreversible changes due to stress |
08/18/1999 | CN1226169A Use of uridine triphosphates and related compounds for prevention and treatment of pneumonia in immobilized patients |
08/17/1999 | US5939555 Polymorphs B and C of 1- 2,4-dichloro-β- (7-chlorobenzo b!thien-3-yl)methoxy!phenethyl!imidazole mononitrate |
08/17/1999 | US5939543 Stable solid 2-octynyl adenosine and process for producing the same |
08/17/1999 | US5939402 Treating plasmodium, viral infections or parasites in mammals |
08/17/1999 | US5939290 Modified sialyl Lewisx compounds |
08/12/1999 | WO1999040223A1 Dideoxy dye terminators |
08/12/1999 | WO1999040099A1 5'-deoxycytidine derivatives |
08/12/1999 | WO1999024452A9 Pyrimidine derivatives for labeled binding partners |
08/11/1999 | EP0934330A1 Base-protected nucleotide analogs with protected thiol groups |
08/11/1999 | EP0934325A1 Tetraphosphonate bicyclic trisanhydrides |
08/11/1999 | EP0789706A4 Sugar modified nucleosides and their use for synthesis of oligonucleotides |
08/10/1999 | US5936087 Dibenzorhodamine dyes |
08/10/1999 | US5936080 Compositions and methods for the synthesis of organophosphorus derivatives |
08/10/1999 | US5936077 Solid phase synthesis of oligonucleotides |
08/10/1999 | US5935555 Pharmaceutical formulations for treating cystic fibrosis |
08/10/1999 | CA2004695C Phospholipid nucleosides |
08/05/1999 | WO1999038879A1 Process for producing nucleoside derivatives |
08/05/1999 | WO1999038878A1 Novel synthons for oligonucleotide synthesis |
08/05/1999 | WO1999038877A2 2-(PURIN-9-yl)-TETRAHYDROFURAN-3,4-DIOL DERIVATIVES |
08/05/1999 | WO1999015542A3 Linker nucleoside, and production and use of the same |
08/05/1999 | WO1999014226A3 Bi- and tri-cyclic nucleoside, nucleotide and oligonucleotide analogues |
08/05/1999 | WO1995031429A8 Photocleavable agents and conjugates for the detection and isolation of biomolecules |
08/05/1999 | CA2318748A1 Novel synthons for oligonucleotide synthesis |
08/05/1999 | CA2318278A1 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives |
08/05/1999 | CA2318277A1 Process for producing nucleoside derivatives |
08/03/1999 | US5932719 Process to prepare pyrimidine nucleosides |
07/29/1999 | WO1999037810A1 A method, reagent solution and kits for dna sequencing |
07/29/1999 | WO1999037753A1 Enzyme catalyzed therapeutic agents |
07/29/1999 | WO1999037717A1 Asymmetric cyanine dye quenchers |
07/29/1999 | WO1999037151A1 Method and compositions for promotion of wound healing |
07/29/1999 | WO1999012951A9 Uses of nicotinamide adenine dinucleotide and its analogs for treatment of malignant and infectious diseases |
07/29/1999 | CA2325002A1 Method and compositions for promotion of wound healing |
07/28/1999 | EP0931038A1 Novel substance library and supramolecular complexes produced therewith |
07/27/1999 | US5929046 Pyrimidine and purine derivatives and their use in treating tumour cells |
07/27/1999 | US5928919 Mutant family b enzymes with reduced or non 3' to 5' exonuclease activity; for high quality (sanger) chain stopping sequencing reactions |
07/27/1999 | US5928862 Competitive homogeneous assay |